Publicações

Shorter Time to Discontinuation Due to Treatment Failure in People Living with Hiv Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort

AuthID
P-00W-D9Q

Author(s)

Teira, R

Diaz-Cuervo, H

Aragao, F

Castano, M

Romero, A

Roca, B

Montero, M

Galindo, MJ

Munoz-Sanchez, MJ

Espinosa, N

[+1]·

Martinez, E

[+1]·

Domingo, P

Deig, E

Merino, MD

Geijo, P

Estrada, V

Sepulveda, MA

Garcia, J

Berenguer, J

Curran, A

View all authors

Tipo de Documento

Article in Press

Year published

2022

Publicado

in INFECTIOUS DISEASES AND THERAPY, ISSN: 2193-8229

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1007/s40121-022-00630-y

Pubmed: 35399147

SCOPUS: 2-s2.0-85127816425

Wos: WOS:000779973200001

Source Identifiers

ISSN: 2193-8229

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Nome	Name Order	Nome	Name Order	Nome
1	Teira, R;	2	Diaz-Cuervo, H;	3	Aragao, F;
4	Castano, M;	5	Romero, A;	6	Roca, B;
7	Montero, M;	8	Galindo, MJ;	9	Munoz-Sanchez, MJ;
10	Espinosa, N;	11	Peraire, J;	12	Martinez, E;
13	De la Fuente, B;	14	Domingo, P;	15	Deig, E;
16	Merino, MD;	17	Geijo, P;	18	Estrada, V;
19	Sepulveda, MA;	20	Garcia, J;	21	Berenguer, J;
22	Curran, A;

Shorter Time to Discontinuation Due to Treatment Failure in People Living with Hiv Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Shorter Time to Discontinuation Due to Treatment Failure in People Living with Hiv Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort

Links Úteis

Ajuda